University Hospitals Birmingham NHS Foundation Trust is a regional and national centre for specialist clinical services.
It is home to some of the country’s leading clinical research institutions, and is dedicated to developing and implementing groundbreaking treatments, technologies and techniques.
A Multicenter Randomized Open-Label Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-Line Treatment of Subjects With Unresectable Hepatocellular CarcinomaView Trial
Women’s INternational Transcatheter Aortic Valve Implantation RegistryView Trial
Commensal Organisms & Rapid Diagnosis of Ocular Infections (CO-RADAR)View Trial
Use of venesected blood from patients with haemochromatosis to isolate and culture lmmune cellsView Trial
UK Version of the ESID on-line RegistryView Trial
FOCUS4 – Molecular selection of therapy in colorectal cancer: a molecularly stratified randomised controlled trials programmeView Trial
Using MRI to investigate changes in connectivity structure and function in patients with cortical visual damageView Trial
National guidance for measuring home furniture and fittings to enable user self-assessment and successful fit of minor assistive devicesView Trial
Adjuvant peginterferon alfa-2b for 2 years vs Observation in patients with an ulcerated primary cutaneous melanoma with T(2-4)bN0M0: A randomized phase III trial of the EORTC Melanoma GroupView Trial
A randomised double-blind placebo controlled trial of the effectiveness of low dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary diseaseView Trial